| Cas No.: | 1342276-76-9 |
| 名称: | 1-(3-Methoxybenzyl)-3-[4-(pyridin-4-yl)thiazol-2-yl]urea |
| 别名: | PKI1313,PKI 1313 |
| SMILES: | N(CC1=CC=CC(OC)=C1)C(NC1=NC(C2C=CN=CC=2)=CS1)=O |
| 分子式: | C17H16N4O2S |
| 分子量: | 340.4 |
| 纯度: | |
| 保存条件: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | |
| In Vivo: | |
| In Vitro: | |
| References: | RKI-1313 is the negative control for RKI-1447 which is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer |
| Kinase Assay: | |
| Cell Assay: | |
| Animal Administration: | |
| References: |
MSDS
| TITLE | DOWNLOAD |
| MSDS_2522_DC8831_1342276-76-9 |
|
COA
| LOT NO. | DOWNLOAD |
|
|
